TransMedics : Acquisition/Asset Disposal - Form 8-K
November 13, 2023 at 05:17 pm EST
Share
Item 1.01.
Entry into a Material Definitive Agreement.
On November 9, 2023, TransMedics Group, Inc. (the "Company") entered into a third amendment to the credit agreement (the "Third Amendment"), which amends that certain credit agreement, dated as of July 25, 2022 (as amended by the First Amendment to Credit Agreement, dated as of May 8, 2023, as further amended by the Second Amendment to Credit Agreement, dated as of June 23, 2023, the "Credit Agreement"), with Canadian Imperial Bank of Commerce ("CIBC"), which, among other items, permits the Company to make acquisitions of equity or assets of another entity, subject to the conditions under the Third Amendment, without further consent of CIBC, for cash consideration in a maximum aggregate amount for all such acquisitions of $300.0 million. Additionally, pursuant to the Third Amendment, aircraft and related assets are designated as excluded assets under the Guarantee and Collateral Agreement.
The foregoing summary description of the Third Amendment is qualified in its entirety by reference to the complete text of the Third Amendment, a copy of which is included as Exhibit 10.1 to this Current Report on Form 8-Kand is incorporated herein by reference.
Transmedics Group Inc. published this content on 13 November 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 November 2023 22:16:06 UTC.
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside of the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ retrieval, OCS organ management and logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation, ground transportation and other coordination activity. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
TRANSMEDICS GROUP, INC. 
